Trials / Unknown
UnknownNCT00223067
Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
A Multi-Center Open-Labeled Study of the Administration of Allogenic and Autologous Regulatory Cells for the Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor)
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (planned)
- Sponsor
- University Hospital Schleswig-Holstein · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
reduce of immunsupression or introduce tolerance with so called TAIZ-monocytes in renal transplant patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAIZ |
Timeline
- Start date
- 2005-03-01
- Completion
- 2006-05-01
- First posted
- 2005-09-22
- Last updated
- 2005-10-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00223067. Inclusion in this directory is not an endorsement.